logo

AZN’s Stock Market Pendulum: Swinging Between Gains and Losses

THMO

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 2.48% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 1.34%. Over the past 30 days, the price of AZN has fallen by 2.95%. And in the last five days, it has surged by 1.95%.

The market performance of Astrazeneca plc ADR has been somewhat unstable. Over the past year, the company’s stock achieved a high of $76.56 on 04/25/23, with the lowest value for the same timeframe being $60.47, recorded on 02/12/24.

52-week price history of AZN Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Astrazeneca plc ADR’s current trading price is -9.85% away from its 52-week high, while its distance from the 52-week low is 14.14%. The stock’s price range for this period has been between $60.47 and $76.56. The Healthcare sector company’s shares saw a trading volume of about 3.47 million for the day, which was lower than the average daily volume of 6.37 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -0.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 213.99B and boasts a workforce of 89900 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 66.06, with a change in price of +4.99. Similarly, Astrazeneca plc ADR recorded 5,849,632 in trading volume during the last 100 days, posting a change of +7.78%.

AZN’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.59.

AZN Stock Stochastic Average

As of today, the raw stochastic average of Astrazeneca plc ADR over the last 50 days is at 90.10%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 80.49%. Further, the company’s Stochastic %K and %D values for the last 20 days were 81.45% and 81.53%, respectively.